Category: Vaccine Headlines
Building Vaccine Trust Among the General Public
Med News Today No longer “a single transcendent reference point for decision-making,” says Gregory Poland, MD Vaccine hesitancy and refusal to be vaccinated are major reasons mass vaccination strategies do not reach the intended coverage, even if adequate vaccine supply has been achieved. Public perceptions of vaccines are critical in reaching protective levels of herd […]
Mar 28, 2023
Do We Need a Spring COVID-19 Booster?
MedPageToday It’s been close to 6 months since the initial rollout of the fall (bivalent) booster. A lot of people are wondering: Do I need a spring booster? The answer hinges on more questions: What is the purpose of vaccines? Does that purpose change depending on age or health status? The Purpose of the COVID Vaccines Last […]
Mar 28, 2023
FDA May Authorize Additional Covid-19 Booster Shots
WSJ Agency officials could make the decision on clearing another round for people at high risk within a few weeks. Federal health regulators are nearing a decision on whether to authorize a second round of the Omicron-targeted booster shots for the elderly and other people at high-risk of severe Covid-19, people familiar with the agency’s deliberations said. […]
Mar 21, 2023
More Young Kids Can Get Bivalent COVID Booster
MedPageToday Pfizer’s booster authorized in children under 5 who received three doses of monovalent vaccine More children under age 5 are now eligible for a COVID-19 booster, the FDA announced on Tuesday. Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster […]
Mar 14, 2023
The COVID booster state of play
Axios It’s been six months since many of us got the bivalent COVID booster, which means you may be wondering: Is it time for a new one? Catch up quick: Federal officials are considering a plan to do yearly one-dose boosters, similar to annual flu shots in the fall, with higher-risk groups eligible for at least […]
Mar 14, 2023
Too Little Sleep Could Make Vaccination Less Effective
(Neuroscience News) How strongly a vaccine protects you may depend on getting enough sleep in the days before and after inoculation, finds a new meta-analysis examining the relationship between sleep duration and the body’s response to vaccination. Link to study Sleeping fewer than six hours per night around the time of vaccination was associated with […]
Mar 14, 2023
New Covid Boosters’ Protection Waned After Two Months, Study Says
Bloomberg Covid-19 bivalent boosters’ protection against death and hospitalization in elderly people began waning as soon as two months after vaccination, according to a preprint study. Link to Study The findings build on previous reports about the effectiveness of updated boosters from Moderna Inc. and Pfizer Inc., which showed the shots sharply reduced risks of severe Covid in older adults, […]
Mar 7, 2023
U.S. Considers Vaccinating Chickens as Bird Flu Kills Millions of Them
(New York Times) The largest outbreak of avian influenza in U.S. history has driven up egg prices and raised concerns about a human pandemic, though C.D.C. experts say the risk of that is low. The Biden administration, keeping a watchful eye on an outbreak of avian influenza that has led to the deaths of tens […]
Mar 7, 2023
Nature Adjuvant-containing subunit vaccines represent a promising approach for protection against tuberculosis (TB), but current candidates require refrigerated storage. Here we present results from a randomized, double-blinded Phase 1 clinical trial (NCT03722472) evaluating the safety, tolerability, and immunogenicity of a thermostable lyophilized single-vial presentation of the ID93 + GLA-SE vaccine candidate compared to the non-thermostable two-vial vaccine […]
Mar 7, 2023
Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
NIH A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes […]
Mar 7, 2023